Quest to sell Thermo Fisher's peanut allergy diagnostic

Thermo Fisher Scientific ($TMO) has inked a distribution deal with Quest Diagnostics ($DGX) for its peanut allergy tests. Neither side is disclosing financial terms, but the non-exclusive deal calls for Quest to market the company's ImmunoCAP Peanut Component blood test to physicians across the country. The arrangement also allows both companies to co-market ImmunoCAP test services offered at Quest clinical laboratories. Release